You are currently viewing a new version of our website. To view the old version click .
  • Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.

Journal of Market Access & Health Policy, Volume 7, Issue 1

January 2019 - 30 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (30)

  • Article
  • Open Access
15 Citations
672 Views
15 Pages

The Impact of Non-medical Switching among Ambulatory Patients: An Updated Systematic Literature Review

  • Erin R. Weeda,
  • Elaine Nguyen,
  • Silas Martin,
  • Michael Ingham,
  • Diana M. Sobieraj,
  • Brahim K. Bookhart and
  • Craig I. Coleman

Background: Non-medical switching (NMS) is defined as switching to a clinically similar but chemically distinct medication for reasons apart from lack of effectiveness, tolerability or adherence. Objective: To update a prior systematic review evaluat...

  • Review
  • Open Access
4 Citations
450 Views
6 Pages

Introduction: The appraisal of medicines is often a complex and iterative process. We compared the health technology assessment (HTA) process in England and France taking as a case study the example of ixazomib for multiple myeloma. Methods: We under...

  • Review
  • Open Access
11 Citations
617 Views
11 Pages

Background and Objectives: Utility elicitation studies for schizophrenia generate different utility values for the same health states. We reviewed utility values used in schizophrenia pharmacoeconomic evaluations and evaluated the impact of their sel...

  • Review
  • Open Access
2 Citations
407 Views
10 Pages

Why "American Patients First" Is Likely to Raise Drug Prices outside of the United States

  • Monique Dabbous,
  • Cyprien Milea,
  • Steven Simoens,
  • Clement François,
  • Claude Dussart,
  • Lylia Chachoua,
  • Borislav Borissov and
  • Mondher Toumi

Background: The Trump administration’s ‘American Patients First’ blueprint proposes to reduce drug prices in the USA by increasing drug prices abroad, ex USA. The possibility of the Trump administration to raise drug prices ex USA through legal actio...

  • Article
  • Open Access
1 Citations
627 Views
7 Pages

Medico-Economic Study of Pain in an Emergency Department: A Targeted Literature Review

  • Claude Dussart,
  • Julien Gelas,
  • Loïc Geffroy,
  • Humbert de Fréminville and
  • Virginie-Eve Lvovschi

Background: Pain management in emergency departments is a complex objective. The absence of a care pathway or a high level of activity complicates diagnostic or analgesic therapeutic strategies. Medical innovation can impact both individual practices...

  • Article
  • Open Access
31 Citations
716 Views
7 Pages

Economic Burden for Alzheimer’s Disease in China from 2010 to 2050: A Modelling Study

  • Emilie Clay,
  • Junwen Zhou,
  • Zhan-Miao Yi,
  • Suodi Zhai and
  • Mondher Toumi

Objectives: We aimed to conduct a modelling study to estimate and predict the economic burden of AD to support the healthcare management of AD in China. Methods: The economic burden of AD was estimated with an evaluation of the prevalence of AD patie...

  • Article
  • Open Access
1 Citations
517 Views
9 Pages

Creation and Validation of a Linear Index to Measure the Health State of Patients with Depression in Automated Healthcare Databases

  • Maëlys Touya,
  • François-Xavier Lamy,
  • Adrian Tanasescu,
  • Delphine Saragoussi,
  • Clément François,
  • Alan G. Wade,
  • Pierre-Michel Llorca,
  • Christophe Lançon and
  • Bruno Falissard

Background and objective: We previously built a weighted Depressive Health State Index (DHSI) based on 29 parameters routinely collected in an automated healthcare database (AHDB). We now propose a linear DHSI (L-DHSI) which is easier to use and to r...

  • Article
  • Open Access
82 Citations
1,659 Views
14 Pages

Cost-Effectiveness Analysis of Using Onasemnogene Abeparvocec (AVXS-101) in Spinal Muscular Atrophy Type 1 Patients

  • Daniel C. Malone,
  • Rebecca Dean,
  • Ramesh Arjunji,
  • Ivar Jensen,
  • Phil Cyr,
  • Beckley Miller,
  • Benit Maru,
  • Douglas M. Sproule,
  • Douglas E. Feltner and
  • Omar Dabbous

Background: Spinal muscular atrophy type 1 (SMA1) is a devastating genetic disease for which gene-replacement therapy may bring substantial survival and quality of life benefits. Objective: This study investigated the cost-effectiveness of onasemnog...

  • Article
  • Open Access
2 Citations
406 Views
11 Pages

Background: The relative efficacy and safety can vary among drugs over time. Sumatriptan, a first choice drug for acute migraine, can illustrate this phenomenon. Objective: To assess the evolution of the relative efficacy and tolerability of oral su...

  • Article
  • Open Access
1 Citations
359 Views
7 Pages

Management and Clinical Practice of Multiple Face and Scalp Actinic Keratosis in France

  • Jacques Savary,
  • Marie Christelle Tine,
  • Anne Caroline Weber and
  • Julie Dorey

Background: Actinic keratosis (AK) is characterized by the occurrence of thick and scaly skin areas caused by damage from ultraviolet radiation. The management of AK aims to reduce lesions and prevent their recurrence by regular monitoring. French gu...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Mark. Access Health Policy - ISSN 2001-6689